Literature DB >> 15559647

Juvenile arthritis-associated uveitis: visual outcomes and prognosis.

Celia S Chen1, Don Roberton, Michael E Hammerton.   

Abstract

BACKGROUND: The current issues in the management of uveitis associated with juvenile arthritis revolve mainly around the treatment of mild disease and how to treat patients with more severe disease. The aims of this study were to determine the incidence of uveitis in a cohort of patients with juvenile arthritis as well as the nature of treatment and the risk factors for visual loss.
METHODS: Review of the charts of 71 patients with juvenile arthritis, as defined by the American Academy of Rheumatology, seen between 1992 and 2001 at a combined rheumatology and ophthalmology clinic. Information collected included the patient's sex, age at diagnosis of arthritis and uveitis, and date of diagnosis of arthritis and uveitis. The rheumatologic diagnosis, results of serologic testing, and details of systemic and topical treatments were also recorded.
RESULTS: There were 47 girls and 24 boys ranging in age from 16 months to 13 years. The median age at diagnosis of juvenile arthritis was 4 years and 1 month. Twenty-seven patients (38%) had uveitis. The median age at uveitis onset was 5.9 years, with an average interval of 18 months from the diagnosis of arthritis; 11 patients had uveitis at the time of arthritis diagnosis. There was a positive relation between anti-nuclear antibody positivity and the development of uveitis (p < 0.05). Thirteen (48%) of the 27 patients with uveitis had mild anterior segment inflammation, with fewer than 25 cells in the anterior chamber. This group had spontaneous resolution of uveitis without topical therapy. All the patients without uveitis had a final visual acuity of 6/9 or better. Five of the patients with uveitis had a final visual acuity of 6/36 or worse. Cataract was the most common complication affecting visual outcome. Cataract extraction initially improved the visual acuity, but posterior segment complications and glaucoma compromised the final visual outcome.
INTERPRETATION: We found an incidence of uveitis of 38% with long-term follow-up of patients with juvenile arthritis; the uveitis was diagnosed an average of 18 months after the arthritis. Almost half of the patients with uveitis had minor anterior segment inflammation. These patients did not receive topical treatment and had good visual outcomes. Patients with uveitis at the time of diagnosis of arthritis tended to have a worse visual prognosis and experienced persistent uveitis despite treatment. In this series, cataract extraction was beneficial in improving visual acuity immediately postoperatively, but posterior segment changes and glaucoma may compromise final visual outcomes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15559647     DOI: 10.1016/s0008-4182(04)80026-7

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  17 in total

1.  Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis.

Authors:  Fasika Woreta; Jennifer E Thorne; Douglas A Jabs; Sanjay R Kedhar; James P Dunn
Journal:  Am J Ophthalmol       Date:  2006-12-20       Impact factor: 5.258

Review 2.  Prevention and management of cataracts in children with juvenile idiopathic arthritis-associated uveitis.

Authors:  Sheila Angeles-Han; Steven Yeh
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

3.  Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for Juvenile Idiopathic Arthritis-Associated and Idiopathic Chronic Anterior Uveitis.

Authors:  Sheila T Angeles-Han; Mindy S Lo; Lauren A Henderson; Melissa A Lerman; Leslie Abramson; Ashley M Cooper; Miriam F Parsa; Lawrence S Zemel; Tova Ronis; Timothy Beukelman; Erika Cox; H Nida Sen; Gary N Holland; Hermine I Brunner; Andrew Lasky; C Egla Rabinovich
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-04       Impact factor: 4.794

4.  High-dose daclizumab for the treatment of juvenile idiopathic arthritis-associated active anterior uveitis.

Authors:  H Nida Sen; Grace Levy-Clarke; Lisa J Faia; Zhuqing Li; Steven Yeh; Karyl S Barron; John G Ryan; Keri Hammel; Robert B Nussenblatt
Journal:  Am J Ophthalmol       Date:  2009-08-06       Impact factor: 5.258

5.  Incidence and outcomes of uveitis in juvenile rheumatoid arthritis, a synthesis of the literature.

Authors:  Petros E Carvounis; David C Herman; Stephen Cha; James P Burke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-14       Impact factor: 3.117

6.  Juvenile idiopathic arthritis-associated uveitis: Data from a region in western Greece.

Authors:  Ioannis Asproudis; Taxiarchis Felekis; Elena Tsanou; Spiridon Gorezis; Eikaterini Karali; Sapfo Alfantaki; Antigoni Siamopoulou-Mauridou; Miltiadis Aspiotis
Journal:  Clin Ophthalmol       Date:  2010-04-26

7.  The Association of Race With Childhood Uveitis.

Authors:  Sheila T Angeles-Han; Courtney McCracken; Steven Yeh; Kirsten Jenkins; Daneka Stryker; Curtis Travers; Kelly Rouster-Stevens; Larry B Vogler; Scott R Lambert; Carolyn Drews-Botsch; Sampath Prahalad
Journal:  Am J Ophthalmol       Date:  2015-08-06       Impact factor: 5.258

8.  Risk markers of juvenile idiopathic arthritis-associated uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry.

Authors:  Sheila T Angeles-Han; Christina F Pelajo; Larry B Vogler; Kelly Rouster-Stevens; Christine Kennedy; Lori Ponder; Courtney McCracken; Jorge Lopez-Benitez; Carolyn Drews-Botsch; Sampath Prahalad
Journal:  J Rheumatol       Date:  2013-11-01       Impact factor: 4.666

9.  Updates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis.

Authors:  Sheila T Angeles-Han; Steven Yeh; Larry B Vogler
Journal:  Int J Clin Rheumtol       Date:  2013-02-01

10.  Characteristics of a cohort of children with Juvenile Idiopathic Arthritis and JIA-associated Uveitis.

Authors:  Sheila T Angeles-Han; Courtney McCracken; Steven Yeh; Kirsten Jenkins; Daneka Stryker; Kelly Rouster-Stevens; Larry B Vogler; Scott R Lambert; Carolyn Drews-Botsch; Sampath Prahalad
Journal:  Pediatr Rheumatol Online J       Date:  2015-06-02       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.